GFAP and Alzheimer disease: The temporal relationships for pre-AD among blood-based biomarkers, such as plasma β-amyloid (Aβ)42/Aβ40, neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), and phosphorylated tau (p-tau) variants, can provide valuable insights into disease progression and support early diagnosis.